The beginning of 2018 has been characterized by a continued high pace, both in terms of sales and distribution agreements in new markets. The production set of the TetraGraph system is complete and sales have started. The level of interest in our products is high and we have already delivered some thirty systems.

During the quarter, we have signed distribution agreements with new partners in Spain, Portugal, South Korea, and after the reporting period, also in Belgium, the Netherlands, Luxembourg, Austria, the Czech Republic and Slovakia. Together with earlier distribution agreements and the licensing agreement with Fukuda Denshi in Japan, we now have distribution agreements in 13 markets outside Sweden. We expect that distribution agreements for additional markets will be signed during the current year.

In order to further accelerate international rollout and strengthen our position in negotiations with potential strategic partners, we have conducted a targeted issue of approximately MSEK 25, including Segulah Venture, during the quarter.

At the beginning of the year, we also signed a partnership agreement with Philips, which was a milestone for Senzime. The collaboration with Philips, a global patient information service provider, enables data from TetraGraph to be displayed on all Philips IntelliVue patient monitors worldwide. Two further patent applications have also been submitted to strengthen the protection of our TetraGraph system.

Senzime continues to make great strides. We have unique, CE-approved medical devices that cost-effectively can prevent millions of healthcare complications – every year, and we have signed distributor and license agreements for several potentially important markets for us. Given order intake and our assessment of how sales will develop, we look forward to a growing installed base of physiologic measuring instruments, linked to the sale of consumables, which also will result in higher gross margins.

In summary, I say as before – we are looking forward to continue to report on Senzime’s progress in 2018.

Uppsala, May 2018

Lena Söderström, CEO of Senzime AB (publ)